Are long-term non-progressors very slow progressors? insights from the chelsea and westminster HIV cohort, 1988-2010

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Mandalia, Sundhiya ^a   Westrop, Samantha J ^a   Beck, Eduard J ^b   Nelson, Mark ^a   Gazzard, Brian G ^a   Imami, Nesrina ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS CONTROLLER; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIMIT OF DETECTION; LONG TERM NONPROGRESSOR; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; OPPORTUNISTIC INFECTION; PATIENT ASSESSMENT; PATIENT IDENTIFICATION; STATISTICAL MODEL; SURVIVAL TIME; VIRUS LOAD; DEMOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; TIME; UNITED KINGDOM; VIROLOGY;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DEMOGRAPHY; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; LONDON; MALE; TIME FACTORS;

EID: 84857385883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029844     Document Type: Article

References (28)

1. Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, et al. (1989) Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 84 (6): 1892-1899.
2. Imami N, Hardy G, Burton C, Pires A, Pido-Lopez J, et al. (2001) Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination. Immunol Lett 79 (1-2): 63-76.
3. Pantaleo G, Fauci AS, (1996) Immunopathogenesis of HIV infection. Annu Rev Microbiol 50: 825-854.
4. CDC (1993) From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 269 (6): 729-730.
5. Westrop SJ, Qazi NA, Pido-Lopez J, Nelson MR, Gazzard B, et al. (2009) Transient Nature of Long-Term Nonprogression and Broad Virus-Specific Proliferative T-Cell Responses with Sustained Thymic Output in HIV-1 Controllers. PLoS ONE 4 (5): e5474.
6. Deeks SG, Walker BD, (2007) Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27 (3): 406-416.
7. Imami N, Pires A, Hardy G, Wilson J, Gazzard B, et al. (2002) A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection. J Virol 76 (18): 9011-9023.
8. Diggle P, Liang K, Zeger S, (1994) Analysis of longitudinal data Oxford Oxford University Press.
9. Zeger S, Liang K, Albert P, (1988) Models for longitudinal data: a generalized estimating equation approach. Biometrics 44: 1049-1060.
10. Kincaid C, (2005) Guidelines for selecting the covariance structure in mixed model analysis. SUGI 30 Proceedings Paper 198-30.
11. Maini MK, Gilson RJ, Chavda N, Gill S, Fakoya A, et al. (1996) Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med 72: 27-31.
12. Tugume SB, Piwowar EM, Lutalo T, Mugyenyi PN, Grant RM, et al. (1995) Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol 2: 233-235.
13. Hulstaert F, Hannet I, Deneys V, Munhyeshuli V, Reichert T, et al. (1994) Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements. Clin Immunol Immunopathol 70 (2): 152-158.
14. Westrop SJ, Jackson A, Gazzard B, Imami N, (2011) HIV-1 Clade A infection and viral control: An immunological perspective on a case of under quantification. International Journal of STD & AIDS 22: 690-692.
15. Easterbrook PJ, (1994) Non-progression in HIV infection. AIDS 8: 1179-1182.
16. Lefrère JJ, Morand-Joubert L, Mariotti M, Bludau H, Burghoffer B, et al. (1997) Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. Blood 90 (3): 1133-1140.
17. Pereyra F, Jia X, McLaren PJ, Telenti A, et al. (2010) The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. International HIV Controllers Study. Science 330: 1551-1557.
18. Migueles SA, Osborne CM, Royce C, Compton AA, Joshi RP, et al. (2008) Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29: 1009-1021.
19. Grabar S, Selinger-Leneman H, Abgrall S, Pialoux G, Weiss L, et al. (2009) Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV. Aids 23: 1163-1169.
20. Barre-Sinoussi F, (2011) Toward an H.I.V. Cure, in The New York Times. 3rd June.
21. Klein MR, Miedema F, (1995) Long-term survivors of HIV-1 infection. Trends in Microbiol 3 (10): 386-391.
22. Cao Y, Qin L, Zhang L, Safrit J, Ho DD, (1995) Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 332 (4): 201-208.
23. Lambotte O, Boufassa F, Madec Y, Nguyen A, Goujard C, et al. (2005) HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis 41: 1053-1056.
24. Walker BD, (2007) Elite control of HIV Infection: implications for vaccines and treatments. Top HIV Med 15 (4): 134-136.
25. Han Y, Lai J, Barditch-Crovo P, Gallant JE, Williams TM, et al. (2008) The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors. Aids 22 (4): 541-544.
26. Aiuti F, D'Offizi G, (1995) Immunologic and virologic studies in long-term non-progressor HIV infected individuals. NOPHROCO Study Group. Non progressors HIV+ Roman cohort. J Biol Regul Homeost Agents 9 (3): 82-87.
27. Migueles SA, Connors M, (2010) Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV. Jama 304 (2): 194-201.
28. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, et al. (2000) HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A 97 (6): 2709-2714.